These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 25352232)

  • 1. Blockade of brain angiotensin II type 1 receptor inhibits the development of atrial fibrillation in hypertensive rats.
    Nagayama T; Hirooka Y; Kishi T; Mukai Y; Inoue S; Takase S; Takemoto M; Chishaki A; Sunagawa K
    Am J Hypertens; 2015 Apr; 28(4):444-51. PubMed ID: 25352232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sympathoinhibition caused by orally administered telmisartan through inhibition of the AT₁ receptor in the rostral ventrolateral medulla of hypertensive rats.
    Kishi T; Hirooka Y; Sunagawa K
    Hypertens Res; 2012 Sep; 35(9):940-6. PubMed ID: 22573203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age.
    Baumann M; Janssen BJ; Hermans JJ; Peutz-Kootstra C; Witzke O; Smits JF; Struijker Boudier HA
    J Hypertens; 2007 Jan; 25(1):207-15. PubMed ID: 17143193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method.
    Araki S; Hirooka Y; Kishi T; Yasukawa K; Utsumi H; Sunagawa K
    Hypertens Res; 2009 Dec; 32(12):1091-6. PubMed ID: 19763130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Dantrolene Treatment Does Not Affect Hypertension, but Attenuates Sympathetic Stimulation Enhanced Atrial Fibrillation Inducibility in SHR.
    Lee JS; Greco L; Migirov A; Li Y; Gerdes AM; Zhang Y
    Am J Hypertens; 2020 Apr; 33(5):407-413. PubMed ID: 32060500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOS pathways in spontaneously hypertensive rats.
    Wang WW; Zhang FL; Chen JH; Chen XH; Fu FY; Tang MR; Chen LL
    Can J Physiol Pharmacol; 2015 Aug; 93(8):657-65. PubMed ID: 26158699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection.
    Peng F; Lin J; Lin L; Tang H
    Int J Mol Med; 2012 Dec; 30(6):1376-86. PubMed ID: 23064712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal medullary effects of transient prehypertensive treatment in young spontaneously hypertensive rats.
    Baumann M; Janssen BJ; Rob Hermans JJ; Bartholome R; Smits JF; Struijker Boudier HA
    Acta Physiol (Oxf); 2009 Jun; 196(2):231-7. PubMed ID: 18983459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats.
    Konno S; Hirooka Y; Araki S; Koga Y; Kishi T; Sunagawa K
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):555-60. PubMed ID: 19057394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain AT1 receptor activates the sympathetic nervous system through toll-like receptor 4 in mice with heart failure.
    Ogawa K; Hirooka Y; Kishi T; Sunagawa K
    J Cardiovasc Pharmacol; 2011 Nov; 58(5):543-9. PubMed ID: 21822148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of angiotensin II provides additional benefits in hypertension- and ageing-related cardiac and vascular dysfunctions beyond its blood pressure-lowering effects.
    Demirci B; McKeown PP; Bayraktutan U
    J Hypertens; 2005 Dec; 23(12):2219-27. PubMed ID: 16269964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term inhibition of angiotensin prevents reduction of periarterial innervation of calcitonin gene-related peptide (CGRP)-containing nerves in spontaneously hypertensive rats.
    Hobara N; Gessei-Tsutsumi N; Goda M; Takayama F; Akiyama S; Kurosaki Y; Kawasaki H
    Hypertens Res; 2005 May; 28(5):465-74. PubMed ID: 16156511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of brain Na sensitivity contributes to salt-induced sympathoexcitation and cardiac dysfunction in mice with pressure overload.
    Ito K; Hirooka Y; Sunagawa K
    Circ Res; 2009 Apr; 104(8):1004-11. PubMed ID: 19299647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT(1) receptor antagonist.
    Wu J; Wang Q; Guo J; Hu Z; Yin Z; Xu J; Wu X
    Eur J Pharmacol; 2008 Jul; 589(1-3):220-4. PubMed ID: 18571160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction.
    Zhang W; Huang BS; Leenen FH
    Am J Physiol; 1999 May; 276(5):H1608-15. PubMed ID: 10330245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.